Exec Hires: Elucid Appoints Andrew Miller as CTO

What You Should Know:

– Elucid, Inc., a medical technology company providing physicians with AI-powered imaging analysis software to assess cardiovascular disease, has hired Andrew Miller as its chief technology officer (CTO).

– As CTO, Andrew will lead the technology strategy and oversee the engineering team’s execution. Elucid’s software is the only FDA-cleared non-invasive tool able to accurately characterize arterial plaque, simulating what pathologists would see under a microscope and establishing a histologic ground truth. Elucid is also pursuing an indication for FFRCT, uniquely derived from its PlaqueIQ technology, to non-invasively measure coronary blockages and the extent of ischemia.

Andrew Miller Bio

Miller is a health technology veteran with an acumen for transforming startups and growth-stage companies into mature organizations. His proven history of building diverse, high-performing organizations has led to profitable business and acquisition. He joins Elucid from Engooden Health, where he served as CTO and chief information security officer, responsible for delivery of technology solutions and infrastructure supporting the SaaS and service-based organization in its mission to redefine chronic care management. Prior to his leadership role at Engooden, Miller served as vice president of engineering for Curaspan, a naviHealth company. Previously, he held roles at Oracle as a senior leader in its Health Sciences division, and Phase Forward, among others.

ai
software
medical
fda